Mission Therapeutics

Showing 4 posts of 4 posts found.

FDA approves Mission Therapeutics’ phase 2 clinical trial for acute kidney injury treatment

December 14, 2023
Medical Communications FDA, Mission Therapeutics, Nephrology, acute kidney injury, clinical trial

Mission Therapeutics has announced that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application …

Mission Therapeutics announces new non-executive chairman

December 5, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment

Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …

michael_koslowski_picture

Mission Therapeutics appoints new chief medical officer

September 9, 2015
Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics

Mission Therapeutics has announced the appointment of Dr Michael Koslowski as chief medical officer. Dr Koslowski brings over 15 years’ …

dr_goddard

Mission Therapeutics appoints Dr Colin Goddard to its board of directors

July 2, 2015
Research and Development Colin Goddard, Mission Therapeutics, appointments

MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, …

Latest content